TRP_1170x120_3-8-19

Joaquin Duato

Amgen CEO elected as PhRMA chairman

Amgen CEO elected as PhRMA chairman

WASHINGTON — Pharmaceutical Research and Manufacturers of America (PhRMA) has named Amgen Inc. chairman and chief executive officer Robert Bradway as chairman-elect. Bradway will succeed Joaquin Duato, executive vice president and worldwide chairman of pharmaceuticals at Johnson & Johnson, as PhRMA chairman in February 2018. Previously, Bradway served as board treasurer for PhRMA. Sanofi CEO

PhRMA sets new criteria for membership

PhRMA sets new criteria for membership

WASHINGTON — The Pharmaceutical Research and Manufacturers of America (PhRMA) this week approved new criteria for membership. With the move, biopharmaceutical companies will have to meet new research-and-development requirements to be eligible to join the organization. PhRMA said the updated membership criteria, which go into effect immediately, came after a three-month review by its board

PhRMA elects officers, welcomes new member UCB

PhRMA elects officers, welcomes new member UCB

WASHINGTON — The Pharmaceutical Research and Manufacturers of America (PhRMA) board of directors has elected new officers and ushered in a new member company. Joaquin Duato, worldwide chairman of pharmaceuticals at Johnson & Johnson, was elected chairman. Joseph Jimenez, chief executive officer of Novartis AG, was elected chairman-elect, and Amgen chairman and CEO Robert Bradway

J&J’s Joaquin Duato tabbed as PhRMA chairman

J&J’s Joaquin Duato tabbed as PhRMA chairman

WASHINGTON — The Pharmaceutical Research and Manufacturers of America has named Joaquin Duato, worldwide chairman of pharmaceuticals as Johnson & Johnson, as chairman of the PhRMA board of directors. Duato previously was chairman-elect on the PhRMA board and succeeds George Scangos, who has stepped down as chief executive officer of Biogen. “In the words of